UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	November 18, 2019

Accession Number:	0000950157-19-001303
Submission Type:	POS AM
CIK: 0001685071 Company Name: Dova Pharmaceuticals Inc. File Number: 333-226403